Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Jonathan Love

Psychiatry Quincy, MA Medical Doctor

NPI 1790212041 CMS profile 8977904

859 Willard St Ste 400, Quincy, MA 02169

Open in the dashboard

General payments

$2,524

108 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonathan Love of Quincy, MA is reported in the CMS Open Payments database as having received $2,524 across 108 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $583 24
2024 General $865 39
2023 General $664 28
2022 General $412 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Love
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Jonathan Love were reported at $583. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Jonathan Love Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $412 $153 $50–$590 $149
2023 $664 $170 $56–$651 $160
2024 $865 $179 $57–$673 $164
2025 $583 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. ITI, Inc. $581 29 payments
  2. AbbVie, Inc. $383 19 payments
  3. Otsuka America Pharmaceutical, Inc. $244 10 payments
  4. Bausch Health US, LLC $187 8 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $178 8 payments
  6. Vanda Pharmaceuticals Inc. $161 6 payments
  7. Neurocrine Biosciences, Inc. $140 5 payments
  8. Lundbeck LLC $131 4 payments
  9. Alkermes, Inc. $116 4 payments
  10. Supernus Pharmaceuticals, Inc. $84 4 payments
  11. Other $318 11 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $2,463 106 payments
  2. Education $61 2 payments
Products named General payments · program years 2022–2025
  1. CAPLYTA Psychiatry $414 20 payments
  2. VRAYLAR $323 16 payments
  3. APLENZIN $187 8 payments
  4. TRINTELLIX $178 8 payments
  5. CAPLYTA Psychiatry $168 9 payments
  6. FANAPT $161 6 payments
  7. INGREZZA $140 5 payments
  8. REXULTI Psychiatry $131 4 payments
  9. REXULTI Psychiatry $125 5 payments
  10. ABILIFY MYCITE $119 5 payments
  11. Other $1,143 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record